Inventor
Jay R. Luly
Inventor
Libertyville, IL, US
Overview
Patents· 61 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides11%
C07HSugars9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07CAcyclic or carbocyclic compounds1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,034,8935, 6-D20189,718,851'Deuterated nucleoside/tide derivatives'20179,663,537'Chemokine receptor antagonists and methods of use'20178,653,096'Chemokine receptor antagonists and methods of use thereof'20148,058,287'Chemokine receptor antagonists and methods of use therefor'20117,897,765'Therapeutic compounds and uses thereof'20117,541,365'Chemokine receptor antagonists and methods of use therefor'20097,504,506'Therapeutic compounds and uses thereof'20097,271,176'Chemokine receptor antagonists and methods of use thereof'20077,186,729'Chemokine receptor antagonists and methods of use thereof'20076,613,905'Chemokine receptor antagonists and methods of use therefor'20036,548,499'Substituted quinoxaline derivatives as interleukin-8 receptor antagonists'20036,509,346'Chemokine receptor antagonists and methods of use therefor'20036,503,926'Chemokine receptor antagonists and methods of use therefor'20036,495,569'Imidazolidine compounds'20026,469,002'Imidazolidine compounds'20026,433,165'Chemokine receptor antagonists and methods of use therefor'20026,329,385'Chemokine receptor antagonists and methods of use therefor'20016,288,083'Chemokine receptor antagonists and methods of use therefor'20016,288,084'Chemokine receptor antagonists and methods of use therefor'20016,166,013'Glucocortiocoid-selective agents'20005,731,320'Macrocyclic amide and urea immunomodulators'19985,708,002'Macrocyclic immunomodulators'19985,672,605'Macrolide immunomodulators'19975,663,148'Anaphylatoxin receptor ligands containing lipophilic residues'19975,643,918'Marcrocyclic amide and urea immunomodulators'19975,612,350'Macrocyclic immunomodulators with novel cyclohexyl ring replacements'19975,604,234'Substituted thiol macrolactam immunomodulators'19975,604,294'Macrocyclic immunomodulators'19975,599,927'Macrocyclic immunomodulators with novel cyclohexyl ring replacements'19975,583,139'Marcolide immunomodulators'19965,563,172'Macrocyclic amide and urea immunomodulators'19965,561,137'Thio-heterocyclic macrolactam immunomodulators'19965,561,228'Macrocyclic immunomodulators'19965,561,139'Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators'19965,561,140'Substituted alicyclic amine-containing macrocyclic immunomodulators'19965,541,193'Heterocycle-containing macrocyclic immunomodulators'19965,541,189'Substituted aliphatic amine-containing macrocyclic immunomodulators'19965,534,632'Macrocyclic carbamate immunomodulators'19965,530,119'Substituted alicyclic amine-containing macrocyclic immunomodulators'19965,530,120'Substituted alicyclic aliphatic-amine containing macrocyclic immunomodulators'19965,527,907'Macrolide immunomodulators'19965,508,397'Activated macrolactams'19965,457,111'Macrocyclic immunomodulators'19955,457,194'Substituted aliphatic amine-containing macrocyclic immunomodulators'19955,387,671'Hexa- and heptapeptide anaphylatoxin-receptor ligands'19955,386,011'Hexapeptide anaphylatoxin-receptor ligands'19955,223,485'Anaphylatoxin-receptor ligands'19935,214,129'Peptidylaminodiols'19935,190,922'Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands'19935,091,575'Peptidylaminodiols'19925,032,577'Peptidylaminodiols'19914,977,277'Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof'19904,857,507'Angiotensinogen analogs'19894,837,204'Functionalized peptidyl aminodiols and -triols'19894,826,815'Renin inhibiting compounds'19894,725,584'Peptidyl-1-amino-2,4-diols'19884,725,583'Functionalized peptidylaminoalcohols'19884,680,284'Modified phenylalanine peptidylaminodiols'19874,652,551'Renin inhibiting compounds'19874,645,759'Renin inhibiting compounds'1987Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1987–2000Patents assigned to ABBOTT LAB (40)· patent assignee history
1987–1998Based in Libertyville, IL, US· patent location history
1987Based in Lake Bluff, IL, US· patent location history
1995Based in Liverty Ville, IL, US· patent location history
2000–2018Based in Wellesley, MA, US· patent location history
2001–2017Patents assigned to MILLENNIUM PHARM INC (14)· patent assignee history
2001–2009Patents assigned to KYOWA HAKKO KOGYO KK (11)· patent assignee history
2011–2017Patents assigned to KYOWA HAKKO KIRIN CO LTD (3)· patent assignee history
2011–2014Patents assigned to CARSON KENNETH G (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 40 | 1987–2000 |
| MILLENNIUM PHARM INC | 14 | 2001–2017 |
| KYOWA HAKKO KOGYO KK | 11 | 2001–2009 |
| KYOWA HAKKO KIRIN CO LTD | 3 | 2011–2017 |
| CARSON KENNETH G | 2 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Libertyville, Illinois, US | 37 | 1987–1998 |
| Wellesley, Massachusetts, US | 21 | 2000–2018 |
| Lake Bluff, Illinois, US | 2 | 1987 |
| Liverty Ville, Illinois, US | 1 | 1995 |